Disclosed is a flow detector (1) for releasable coupling with a flow channel (20) in a channel coupling area and detecting a flow of liquid drug in the flow channel (20), the flow detector including: an upstream thermoelectric element (10a) and a downstream thermoelectric element (10b), wherein the upstream thermoelectric element (10a) and the downstream thermoelectric element (10b) are arranged spaced apart from each other and movable independent from each other; an upstream biasing element (15a) and a downstream biasing element (15b), wherein the upstream biasing element (15a) acts on the upstream thermoelectric element (10a), thereby biasing the upstream thermoelectric element (10a) towards the channel coupling area, and the downstream biasing element (15b) acts on the downstream thermoelectric element (10b), thereby biasing the downstream thermoelectric element (10b) towards the channel coupling area independently from the upstream biasing element (15a).

Infusion devices, systems, and related operating methods are provided. A method of detecting an anomalous condition with respect to a fluid path based on operation of an actuation arrangement configured to deliver fluid via the fluid path involves providing input power to the actuation arrangement to produce actuation of the actuation arrangement, identifying an active amount of actuation of the actuation arrangement concurrent to the input power being provided to the actuation arrangement, disabling the input power to the actuation arrangement, identifying a passive amount of actuation of the actuation arrangement after disabling the input power to the actuation arrangement, and detecting the anomalous condition based on a relationship between the active amount and the passive amount.

An aspect of the invention provides a method and a product for determining a modification of the therapy management by using a processor unit which retrieves few data related to the blood glucose measurement performed over a predetermined time period; retrieve the medication delivery parameter executed by the delivery device over said predetermined time period; retrieve from the memory data associated to the CIR of the patient; and determine a modification to the therapy based on at least a part of the retrieved data.

Disclosed is a supervision device (9) for supervising liquid drug flow in a flow channel (20). The supervision device (9) includes a flow detector (1), arranged for operatively coupling with the flow channel (20) and generating a flow detector signal in dependence of a flow in the flow channel (20) at a flow detection location. The supervision device (9) further includes a gas detector (8), arranged for operatively coupling with the flow channel (20) and generating a gas detector signal in dependence of whether liquid drug or gas is present in the flow channel (20) at a gas detection location at a distance upstream from the flow detection location. The supervision device (9) further includes a processing unit (90) in operative coupling with the flow detector (1) and the gas detector (8), wherein the processing unit (90) is configured to determine, based on the gas detector signal, whether non-flowing liquid drug is present at the flow detection location or a gas bubble passes the flow detector if the flow detector signal does not indicate a liquid drug flow.

An infusion pump device comprises a pump unit having an inlet and an outlet, a connector being in fluid communication with the inlet of said pump unit, a medication reservoir accommodation portion for accommodating a medication reservoir having a label or tag so that an outlet of the medication reservoir is to be coupled to said connector, and a reader which is provided at said medication reservoir accommodation portion so that the reader is adapted to read a label or tag of the medication reservoir when arranged at said medication reservoir accommodation portion.

A peristaltic infusion pump tube segment comprises a first tube portion having a surrounding wall adapted for an upstream occlusion detection, a second tube portion downstream of said first tube portion and adapted to be temporally engaged by an engagement structure, wherein said second tube portion comprises a surrounding wall being at least partly thicker than the wall of said first tube portion and made of an elastic material which allows said second tube portion to be essentially reformed at those portions which are currently not subject to the engagement by the engagement structure, a third tube portion downstream of said second tube portion and having a surrounding wall adapted for an air in line detection, and a fourth tube portion adapted for a downstream pressure detection. The peristaltic infusion pump tube segment is provided in an infusion pump device which comprises a pump mechanism configured as a peristaltic mechanism.

A drug delivery system includes a delivery container including a container body adapted to accommodate a drug therein, a supply line, and a flow rate monitor. The delivery container further includes inlet and outlet ports and is constructed from a resilient material that exerts an urging force on the drug to expel the drug from the outlet port. The supply line is operably coupled to the outlet port to deliver the drug to a user. The flow rate monitor is operably coupled to at least one of the delivery container or the supply line and includes a digital controller, a fluid valve operably coupled to the digital controller, and a diaphragm assembly in fluid communication with the fluid valve and operably coupled to the digital controller. The fluid valve, the diaphragm assembly, and the digital controller cooperate to regulate a flow rate of the drug.

A method that includes receiving, in a medication delivery module, a command to start a medication delivery from a first control module coupled to the medication delivery module, is provided. The command to start the medication delivery is based on clinical information received at the first control module. The method includes recording, in a memory of the medication delivery module, an update of the medication delivery, receiving an indication that the medication delivery module was decoupled from the first control module, and receiving an indication that the medication delivery module has become coupled with a second control module. The method also includes communicating, in response, with the second control module, to update the clinical information. A system and a non-transitory, computer readable medium storing instructions to perform the above method are also provided.

A flow control device includes a housing having a primary inlet, a secondary inlet, and an outlet disposed downstream of the primary and secondary inlets. The flow control device further includes a chamber defined by an inner circumferential surface of the housing. The chamber fluidly connects the primary and secondary inlets with the outlet. A valve member is mounted in the chamber to pivot toward and block the primary inlet by fluid pressure in the secondary inlet when fluid pressure into the secondary inlet is higher than fluid pressure into the primary inlet.

A pump for pumping fluid includes a tube platen, a plunger, a bias member, inlet and outlet valves, an actuator mechanism, a position sensor, and a processor. The plunger is configured for actuation toward and away from the infusion-tube when the tube platen is disposed opposite to the plunger. The tube platen can hold an intravenous infusion tube. The bias member is configured to urge the plunger toward the tube platen.